SOD1 and ischemic stroke: In diabetes patients who are susceptible to thrombotic events, such as ischemic stroke, lower GSH, GPx, and SOD-1 levels are noted within platelets, while administration of N-acetylcysteine can reduce the risk of ischemic stroke via enhancing the platelet antioxidant enzyme activity [104].